Volume 34, 5 December 2003 12/2003
 
  SPOT ON
 

German health care reform hinders rational therapy

Myocardial infarction with heart failure: Valsartan (e.g. DIOVAN) and captopril (e.g. LOPIRIN) equally effective?

 
  NEW ON THE MARKET
 

Keep off: Parathyroid hormone fragment teriparatide (FORSTEO) for osteoporosis

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Selective digestive tract decontamination in intensive care patients? Not for routine use!

 
  REVIEW
 

Antioxidants: How useful? (II)

 
  a-t READERS' QUESTIONS AND COMMENTS
 

VALIANT: Misleading promotion for DIOVAN (valsartan)
Theophylline preparation THROMPHYLLIN especially inexpensive?
Bayer Vital: Payed post-graduate educational programme for moxifloxacin (AVALOX) on the internet

 
  CURRENT ADR NETWORK REPORT
 

Visual disturbance associated with rofecoxib (VIOXX) and celecoxib (CELEBREX)
Dysgeusia due to clopidogrel (ISCOVER, PLAVIX) or ticlopidine (e.g. TIKLYD)

 
  SIDE EFFECTS
 

SSRI and related antidepressants: Warning on suicidality in children

 
© arznei-telegramm 12/2003